Accendra Health (ACH) Cash & Equivalents (2009 - 2026)

Accendra Health (ACH) has 18 years of Cash & Equivalents data on file, last reported at $336.9 million in Q1 2026.

• On a quarterly basis, Cash & Equivalents rose 466.79% year-over-year to $336.9 million in Q1 2026; TTM through Mar 2026 was $336.9 million, a 466.79% increase from a year earlier, with the FY2025 full-year figure at $282.0 million, up 922.74% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $336.9 million, up from $282.0 million in the prior quarter.
• Over the last five years, Cash & Equivalents for ACH reached as high as $336.9 million in Q1 2026 and fell as low as $27.6 million in Q4 2024.
• Historically, Cash & Equivalents has averaged $149.2 million across 5 years, with a median of $76.8 million in 2022.
• Across the five-year window, Cash & Equivalents slumped 88.66% in 2024 and soared 922.74% in 2025, its largest moves.
• Year by year, Cash & Equivalents stood at $69.5 million in 2022, then soared by 249.86% to $243.0 million in 2023, then slumped by 88.66% to $27.6 million in 2024, then surged by 922.74% to $282.0 million in 2025, then gained by 19.47% to $336.9 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $336.9 million in Q1 2026, $282.0 million in Q4 2025, and $32.8 million in Q3 2025.